A diagnosis of prostate cancer quickly turns abstract medical terms into practical decisions. For many men, one of the first questions is which prostate cancer surgery options are available, and whether surgery is the right treatment at all.
The answer depends on the stage of the cancer, the grade and aggressiveness of the tumour, your age, general health, urinary and sexual function before treatment, and what matters most to you in recovery. Surgery can be highly effective for localised prostate cancer, but there is no single operation that suits every patient.
When surgery is considered
Surgery is most commonly offered when prostate cancer appears to be confined to the prostate, or when there is a reasonable prospect that removing the prostate will provide strong cancer control. In selected cases, surgery may also form part of treatment for locally advanced disease, sometimes alongside other therapies.
The operation performed for prostate cancer is called a radical prostatectomy. This means removal of the entire prostate gland and seminal vesicles. Depending on the situation, nearby lymph nodes may also be removed for staging and cancer control.
Not every man with prostate cancer needs immediate surgery. Some low-risk cancers are better managed with active surveillance, where the cancer is monitored closely with PSA testing, MRI and repeat biopsy when required. For other men, radiation therapy or hormone treatment may be more appropriate than an operation. That is why specialist assessment is important before deciding on a treatment pathway.
Main prostate cancer surgery options
Robotic radical prostatectomy
Robotic-assisted radical prostatectomy is now a common surgical approach for prostate cancer in appropriately selected patients. The procedure is performed through several small keyhole incisions using robotic instruments controlled by the surgeon.
The main advantage of robotic surgery is precision. Magnified three-dimensional vision and fine instrument control can assist with careful dissection around important structures, including the bladder neck, urethra, neurovascular bundles and surrounding tissues. In many cases, this supports less blood loss, a shorter hospital stay and a faster early recovery compared with traditional open surgery.
For patients, robotic surgery is still major surgery. It requires a general anaesthetic, catheter drainage after the procedure, and a period of recovery at home. The goal is complete cancer removal while preserving urinary continence and erectile function where this is oncologically safe, but those outcomes vary between patients.
Open radical prostatectomy
Open radical prostatectomy is performed through a lower abdominal incision rather than keyhole access. It remains a valid option in some settings and may still be used depending on surgeon expertise, patient anatomy, prior surgery, or hospital availability.
The cancer operation itself follows the same principles as robotic surgery – remove the prostate and seminal vesicles completely, reconnect the bladder to the urethra, and consider lymph node dissection where indicated. The difference is the surgical access rather than the overall intent.
In experienced hands, open surgery can achieve very good cancer outcomes. However, compared with robotic approaches, it is often associated with a larger incision, greater blood loss and a somewhat longer recovery. For many men in South Australia seeking minimally invasive treatment, robotic prostatectomy is now a central part of specialist surgical care.
Radical prostatectomy with pelvic lymph node dissection
Some men need more than removal of the prostate alone. If scans, biopsy findings or PSA level suggest a higher risk that cancer cells may have spread to nearby pelvic lymph nodes, the surgeon may recommend pelvic lymph node dissection at the same time.
This involves removal of selected lymph nodes in the pelvis for pathological examination. It helps provide more accurate staging and can influence whether further treatment is needed after surgery. It does add operative complexity and may increase the risk of complications such as lymphocele formation, so it is used when the clinical benefit is likely to justify it.
How surgeons decide which option is suitable
Choosing between prostate cancer surgery options is not simply a matter of technique. The real question is whether surgery is appropriate, and if so, how to perform it in a way that gives the best balance between cancer control and functional outcome.
Several factors shape that decision. Cancer factors include PSA level, MRI findings, biopsy grade group, clinical stage and whether disease appears localised or more extensive. Patient factors include age, weight, heart and lung health, previous abdominal surgery, baseline urinary symptoms and erectile function.
There are also practical treatment goals. In a younger, otherwise well man with localised intermediate-risk cancer, surgery may offer both excellent cancer control and clear pathological staging. In an older man with significant medical comorbidity or a lower-risk tumour, surveillance or radiation may be more appropriate. This is why a careful consultation matters more than any general article or online comparison.
Nerve-sparing surgery and why it matters
One of the most discussed aspects of radical prostatectomy is whether nerve-sparing surgery is possible. The nerves involved in erectile function run close to the prostate. If the cancer is not involving those areas, the surgeon may be able to preserve one or both neurovascular bundles.
Nerve sparing can improve the chance of recovering erectile function after surgery, but it is not suitable in every case. If the tumour is close to the edge of the prostate or appears to extend beyond it, preserving nerves may increase the risk of leaving cancer behind. In those situations, cancer clearance takes priority.
Even when nerve-sparing surgery is performed, erectile recovery is variable. Age, pre-existing erectile function, diabetes, vascular disease and the extent of dissection all influence the result. Patients should be given a realistic explanation of what surgery can and cannot preserve.
Risks and trade-offs of prostate cancer surgery options
All major prostate surgery carries potential risks. The most significant are urinary incontinence and erectile dysfunction, because these directly affect quality of life after treatment.
Most men will have some degree of urinary leakage in the early recovery period after catheter removal. Many improve substantially over time, especially with pelvic floor rehabilitation, but recovery is not identical for everyone. A smaller group will have persistent stress incontinence requiring pads long term, and a few may need further treatment.
Erectile dysfunction is also common after radical prostatectomy, particularly in older men or where nerve sparing is not possible. Recovery can take many months, and some men will not return to their pre-operative baseline. This should be discussed plainly before surgery rather than treated as an afterthought.
Other recognised risks include bleeding, infection, injury to surrounding structures, anastomotic leak, bladder neck contracture, lymphocele, deep vein thrombosis and anaesthetic complications. These are uncommon but real. Surgery offers strong cancer treatment, but it is never free of trade-offs.
What recovery usually looks like
Most men stay in hospital for a short period after robotic prostatectomy, although this varies with the individual and the hospital. A urinary catheter is usually left in place for around one to two weeks while the bladder and urethra heal.
Fatigue is common in the first few weeks. Walking is encouraged early, but heavy lifting and strenuous activity need to wait. Return to office-based work may be possible within a few weeks for some patients, whereas physically demanding work can take longer.
The pathology result after surgery is a key part of the next step. It confirms the grade, stage, margin status and whether there was spread beyond the prostate or into lymph nodes. That information guides follow-up and whether further treatment, such as radiation, should be considered.
Follow-up after surgery
PSA testing after radical prostatectomy is central to monitoring. Because the prostate has been removed, PSA should drop to a very low or undetectable level. Ongoing blood tests help detect any biochemical recurrence early.
Recovery is not measured by PSA alone. Continence, sexual function, wound healing, bowel recovery and general wellbeing all matter. A good surgical pathway includes structured follow-up, clear instructions and access to specialist review if problems arise.
Robotic surgery in specialist urological care
For men considering surgery in South Australia, access to an experienced urological surgeon with robotic capability can be an important part of decision-making. Practices such as Urology Health Adelaide provide specialist assessment of whether robotic radical prostatectomy is appropriate and whether additional procedures, including lymph node dissection, are indicated.
The key point is not that newer technology is automatically better for every patient. It is that surgical planning, case selection and operative experience matter. Robotic systems are tools. Outcomes still depend on sound judgement, cancer surgery principles and careful follow-up.
If you are weighing prostate cancer surgery options, the most useful next step is a specialist discussion focused on your cancer, your overall health and your priorities after treatment. The right operation is the one that addresses the cancer properly while giving you the clearest understanding of what recovery is likely to involve.
Recent Comments